Novel Insights and therapeutics for Parkinson’s disease

Parkinson’s disease is the essential growth driver of the worldwide Parkinson’s disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. The therapeutics of Parkinson Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinson’s disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.

  • ER Stress Signaling
  • ER Stress in Parkinson’s disease

Related Conference of Novel Insights and therapeutics for Parkinson’s disease

Aug 02-04, 2017

International Meeting on CNS

Melbourne, Australia
August 29-31, 2017

15th European Neurology Congress

London, UK
August 29-31, 2017

6th World Congress on Addiction Disorder & Addiction Therapy

Prague, Czech Republic
August 31-September 01, 2017

3rd International Conference on Epilepsy and Treatment

Brussels, Belgium
September 07-08, 2017

Global Experts Meeting on Brain Disorders

Macau, Hong Kong
Oct 12-13, 2017

Internatinal Meeting on Addiction Congress

Osaka, Japan
Oct 12-13, 2017

Global Meeting on Dual Diagnosis and Addiction

Auckland, Newzeland
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
Nov 13-14, 2017

Gobal Experts Meeting on Neuroscience and Neurochemistry

Melbourne, Australia
February 22-23, 2018

11th International Conference on Vascular Dementia

Paris, France

Novel Insights and therapeutics for Parkinson’s disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in